AU2011300253B2 - TTLL4 peptides and vaccines containing the same - Google Patents

TTLL4 peptides and vaccines containing the same Download PDF

Info

Publication number
AU2011300253B2
AU2011300253B2 AU2011300253A AU2011300253A AU2011300253B2 AU 2011300253 B2 AU2011300253 B2 AU 2011300253B2 AU 2011300253 A AU2011300253 A AU 2011300253A AU 2011300253 A AU2011300253 A AU 2011300253A AU 2011300253 B2 AU2011300253 B2 AU 2011300253B2
Authority
AU
Australia
Prior art keywords
peptide
ttll4
present
seq
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011300253A
Other languages
English (en)
Other versions
AU2011300253A1 (en
Inventor
Yusuke Nakamura
Ryuji Osawa
Takuya Tsunoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of AU2011300253A1 publication Critical patent/AU2011300253A1/en
Application granted granted Critical
Publication of AU2011300253B2 publication Critical patent/AU2011300253B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2011300253A 2010-09-07 2011-09-06 TTLL4 peptides and vaccines containing the same Ceased AU2011300253B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38061110P 2010-09-07 2010-09-07
US61/380,611 2010-09-07
PCT/JP2011/004987 WO2012032764A1 (en) 2010-09-07 2011-09-06 Ttll4 peptides and vaccines containing the same

Publications (2)

Publication Number Publication Date
AU2011300253A1 AU2011300253A1 (en) 2013-03-21
AU2011300253B2 true AU2011300253B2 (en) 2015-01-15

Family

ID=45810374

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011300253A Ceased AU2011300253B2 (en) 2010-09-07 2011-09-06 TTLL4 peptides and vaccines containing the same

Country Status (13)

Country Link
US (1) US20130224234A1 (enExample)
EP (1) EP2614146A4 (enExample)
JP (1) JP2013540419A (enExample)
KR (1) KR20130101529A (enExample)
CN (1) CN103189510B (enExample)
AU (1) AU2011300253B2 (enExample)
BR (1) BR112013005448A2 (enExample)
CA (1) CA2810636A1 (enExample)
MX (1) MX2013002303A (enExample)
RU (1) RU2013115434A (enExample)
SG (1) SG187847A1 (enExample)
TW (1) TW201210608A (enExample)
WO (1) WO2012032764A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015123315A (ru) * 2012-11-25 2017-01-10 Зе Реджентс Оф Зе Юниверсити Оф Калифорния Пептиды, стимулирующие подкожный адипогенез
WO2015184125A1 (en) 2014-05-28 2015-12-03 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
CN111041028B (zh) * 2019-12-20 2024-05-17 陕西省人民医院 人ttll4基因的用途及相关产品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004092207A2 (en) * 2003-04-16 2004-10-28 Algonomics N.V. Respiratory syncytial virus (rsv) peptides
WO2010023856A1 (en) * 2008-08-27 2010-03-04 Oncotherapy Science, Inc. Pancreatic cancer related gene ttll4

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
AU2003254950A1 (en) * 2002-08-26 2004-03-11 Kirin Beer Kabushiki Kaisha Peptides and drugs containing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004092207A2 (en) * 2003-04-16 2004-10-28 Algonomics N.V. Respiratory syncytial virus (rsv) peptides
WO2010023856A1 (en) * 2008-08-27 2010-03-04 Oncotherapy Science, Inc. Pancreatic cancer related gene ttll4

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
UniProt accession no. B4DJF5, 23 September 2008 *

Also Published As

Publication number Publication date
WO2012032764A1 (en) 2012-03-15
EP2614146A1 (en) 2013-07-17
AU2011300253A1 (en) 2013-03-21
CN103189510B (zh) 2015-05-06
SG187847A1 (en) 2013-03-28
CN103189510A (zh) 2013-07-03
RU2013115434A (ru) 2014-10-20
EP2614146A4 (en) 2014-02-12
JP2013540419A (ja) 2013-11-07
MX2013002303A (es) 2013-10-28
KR20130101529A (ko) 2013-09-13
CA2810636A1 (en) 2012-03-15
BR112013005448A2 (pt) 2019-09-24
TW201210608A (en) 2012-03-16
US20130224234A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
AU2011208271B2 (en) Modified MELK peptides and vaccines containing the same
WO2011125334A1 (en) Cdca5 peptides and vaccines including the same
AU2012329502A1 (en) TOPK peptides and vaccines including the same
AU2012265677A1 (en) SEMA5B peptides and vaccines including the same
US20170198010A1 (en) Tomm34 peptides and vaccines including the same
US8530430B2 (en) TTK peptides and vaccines including the same
AU2011300253B2 (en) TTLL4 peptides and vaccines containing the same
AU2011225577B2 (en) HJURP peptides and vaccines including the same
AU2011233401B2 (en) ECT2 peptides and vaccines including the same
US8697631B2 (en) TMEM22 peptides and vaccines including the same
AU2010327891A1 (en) MYBL2 peptides and vaccines containing the same
WO2014087626A1 (en) Sema5b peptides and vaccines containing the same
US20130287805A1 (en) C18orf54 peptides and vaccines including the same
AU2011319359A1 (en) WDHD1 peptides and vaccines including the same
WO2011125139A1 (en) Cluap1 peptides and vaccines including the same

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired